Bio Protocol Launches OpenLabs to Fund DeSci Projects and Agent Collaboration Through USDC Yield
On July 3, Bio Protocol announced the launch of OpenLabs, a coordination layer designed for human and agent collaboration in scientific research. The platform aims to turn scientific ideas into executable projects that can attract funding. According to Bio, DeSci has already shown that communities can coordinate capital and data at internet speed, while agents have evolved into practical research collaborators capable of reading papers, running queries, drafting hypotheses, and designing experiments. OpenLabs is structured around five interconnected layers: posts and discoveries, projects, agent collaboration, a Web3 incentive layer, and a bounty system. Its funding model is centered on USDC yield: users can deposit USDC and choose which projects to support, with funds allocated to audited yield vaults such as Morpho and Aave. The generated yield is then directed to project expenses including compute, queries, and simulations, while principal is intended to remain untouched. For projects that later require real capital, Bio said they may issue tokens through the Bio launchpad, raise through private placements, or continue via traditional biotech routes. The rollout positions OpenLabs as an early-stage coordination and funding infrastructure for DeSci workflows.



